- Home
- ADTX vs CELZ Comparison
ADTX vs CELZ Comparison
Compare ADTX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- CELZ
- Stock Information
- Founded
- ADTX 2017
- CELZ 1998
- Country
- ADTX United States
- CELZ United States
- Employees
- ADTX N/A
- CELZ N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- CELZ Health Care
- Exchange
- ADTX Nasdaq
- CELZ Nasdaq
- Market Cap
- ADTX 5.3M
- CELZ 5.5M
- IPO Year
- ADTX 2020
- CELZ N/A
- Fundamental
- Price
- ADTX $2.30
- CELZ $1.97
- Analyst Decision
- ADTX
- CELZ
- Analyst Count
- ADTX 0
- CELZ 0
- Target Price
- ADTX N/A
- CELZ N/A
- AVG Volume (30 Days)
- ADTX 589.6K
- CELZ 96.9K
- Earning Date
- ADTX 05-19-2025
- CELZ 05-09-2025
- Dividend Yield
- ADTX N/A
- CELZ N/A
- EPS Growth
- ADTX N/A
- CELZ N/A
- EPS
- ADTX N/A
- CELZ N/A
- Revenue
- ADTX $133,985.00
- CELZ $11,000.00
- Revenue This Year
- ADTX $15,768.94
- CELZ N/A
- Revenue Next Year
- ADTX N/A
- CELZ N/A
- P/E Ratio
- ADTX N/A
- CELZ N/A
- Revenue Growth
- ADTX N/A
- CELZ 22.22
- 52 Week Low
- ADTX $2.04
- CELZ $1.69
- 52 Week High
- ADTX $27,200.00
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- ADTX 30.46
- CELZ 39.29
- Support Level
- ADTX $2.21
- CELZ $1.90
- Resistance Level
- ADTX $2.39
- CELZ $2.10
- Average True Range (ATR)
- ADTX 0.39
- CELZ 0.24
- MACD
- ADTX 0.49
- CELZ 0.06
- Stochastic Oscillator
- ADTX 11.11
- CELZ 37.84
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.